CPIG
NVO

Chicago Partners Investment Group’s Novo Nordisk NVO Stock Holding History

Chicago Partners Investment Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Sell
400
-200
-33% -$8.59K ﹤0.01% 1545
2026
Q1 		$23.5K Buy
+600
New +$28.4K ﹤0.01% 1451

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Chicago Partners Investment Group's NVO Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Novo Nordisk (NVO) stake by 12% in Q2 2026, buying an estimated $107K and bringing the position to 22,731 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #612.

Chicago Partners Investment Group first reported a position in NVO in Q2 2017 and has held it in 34 quarters since. The position peaked at $2.26M in Q2 2024. 759 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Chicago Partners Investment Group held 22,731 shares of Novo Nordisk worth $1.1M as of Q2 2026.
  • Chicago Partners Investment Group bought 2,502 Novo Nordisk shares in Q2 2026, an estimated $107K.
  • Novo Nordisk made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #612 holding.
  • Chicago Partners Investment Group first reported a position in Novo Nordisk in Q2 2017 and has held it in 34 quarters since.
  • Chicago Partners Investment Group's Novo Nordisk position peaked at $2.26M in Q2 2024.
  • 759 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.